Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07841613 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Exploring the Impact of Diurnal Variation on Coagulation Function in Patients Undering Tumor Surgery

StatusEnrolling by Invitation
PhaseNot specified
Started2025-06-01
View on ClinicalTrials.gov ↗
624 trials monitored
See 9 trials at risk
Studies have shown that compared to the evening, the platelet adhension and aggregation functions of normal individuals are stronger in the morning, reaching peak at around 8AM or 9AM. Fibrinolysis is weakest at 7-11AM, and most active at midnight. previous studies have been contradictory regarding the rhythm of plasmin. Some show the level of plasmin complexes is highest at night, while some show higher in the morning and some show there is no rhythmicity. Since patients with tumors often have a hypercoagulable state, we try to find a method to assess whether cancer patients have the same circadian with heathy individuals. And whether the surgery time(in the morning or in the evening) will affect the tumor patients' postoperative coagulation function
Trial Details
NCT Number NCT07841613
Lead Sponsor Fudan University
Conditions Diurnal Variation of Coagulation Function
Enrollment 60 participants
Start Date 2025-06-01
Primary Completion 2026-12-30 (estimated)
Study Completion 2027-07-30 (estimated)
Updated on ClinicalTrials.gov 2026-09-25